Vitamin E consumption and the risk of coronary heart disease in men.

PubWeight™: 6.37‹?› | Rank: Top 1%

🔗 View Article (PMID 8479464)

Published in N Engl J Med on May 20, 1993

Authors

E B Rimm1, M J Stampfer, A Ascherio, E Giovannucci, G A Colditz, W C Willett

Author Affiliations

1: Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115.

Associated clinical trials:

Health Professionals Follow-up Study | NCT00005182

Effects of Oral Antioxidant Cocktail in Cardiovascular Disease Patients | NCT03629613

Articles citing this

(truncated to the top 100)

Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A (1993) 13.27

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32

Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A (1996) 4.45

Antioxidants in health and disease. J Clin Pathol (2001) 4.09

A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med (2007) 3.37

CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest (2008) 3.29

Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ (1996) 3.27

The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med (2007) 2.62

The Inadmissibility of What We Eat in America and NHANES Dietary Data in Nutrition and Obesity Research and the Scientific Formulation of National Dietary Guidelines. Mayo Clin Proc (2015) 2.57

Possible association of a reduction in cardiovascular events with blood donation. Heart (1997) 2.39

Anticancer vitamins du Jour--The ABCED's so far. Am J Epidemiol (2010) 2.30

Reactive oxygen species in cardiovascular disease. Free Radic Biol Med (2011) 2.29

Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation (2005) 2.12

Geographic disparities in Healthy Eating Index scores (HEI-2005 and 2010) by residential property values: Findings from Seattle Obesity Study (SOS). Prev Med (2015) 2.08

Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ (2006) 1.93

Dietary determinants of ischaemic heart disease in health conscious individuals. Heart (1997) 1.87

Aortic wall damage in mice unable to synthesize ascorbic acid. Proc Natl Acad Sci U S A (2000) 1.83

Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol (2009) 1.73

Dietary exposures to selected metals and pesticides. Environ Health Perspect (1996) 1.66

Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry (1995) 1.65

Use of genetic markers and gene-diet interactions for interrogating population-level causal influences of diet on health. Genes Nutr (2010) 1.65

Vitamin C in human health and disease is still a mystery? An overview. Nutr J (2003) 1.52

Fish consumption and risk of major chronic disease in men. Am J Clin Nutr (2008) 1.47

Antioxidant vitamins and coronary heart disease. N Engl J Med (1993) 1.45

Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. BMJ (1995) 1.45

Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ (1995) 1.43

Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ (2010) 1.43

Micronutrient concentrations and subclinical atherosclerosis in adults with HIV. Am J Clin Nutr (2010) 1.42

Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality. Am J Epidemiol (2009) 1.42

Tomato lycopene and its role in human health and chronic diseases. CMAJ (2000) 1.39

Oxidative Stress and Inflammation in Heart Disease: Do Antioxidants Have a Role in Treatment and/or Prevention? Int J Inflam (2011) 1.30

Observational versus experimental studies: what's the evidence for a hierarchy? NeuroRx (2004) 1.23

Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol (1995) 1.22

Is plasma vitamin C an appropriate biomarker of vitamin C intake? A systematic review and meta-analysis. Nutr J (2007) 1.21

Antioxidants, inflammation and cardiovascular disease. World J Cardiol (2014) 1.20

Astaxanthin: a potential therapeutic agent in cardiovascular disease. Mar Drugs (2011) 1.19

The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J Clin Invest (1996) 1.19

Limitations of observational evidence: implications for evidence-based dietary recommendations. Adv Nutr (2014) 1.19

Human immunodeficiency virus protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage-derived foam cells. Am J Pathol (2007) 1.17

alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J (1998) 1.16

Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci U S A (1993) 1.16

Intakes of fruits, vegetables and carbohydrate and the risk of CVD. Public Health Nutr (2008) 1.13

Nutrient intakes linked to better health outcomes are associated with higher diet costs in the US. PLoS One (2012) 1.12

Health benefits of selected vitamins. Can Fam Physician (2005) 1.12

Associations of plasma carotenoids with risk factors and biomarkers related to cardiovascular disease in middle-aged and older women. Am J Clin Nutr (2008) 1.10

d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci U S A (1995) 1.07

Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest (1994) 1.06

Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci U S A (1994) 1.06

F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic Biol Med (2010) 1.04

Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-alpha-tocopherol. Proc Natl Acad Sci U S A (1994) 1.02

Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies. Nutrients (2013) 1.02

Vitamin E and all-cause mortality: a meta-analysis. Curr Aging Sci (2011) 1.01

Induction of antioxidant and detoxification response by oxidants in cardiomyocytes: evidence from gene expression profiling and activation of Nrf2 transcription factor. J Mol Cell Cardiol (2006) 1.01

C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells. Arterioscler Thromb Vasc Biol (2007) 1.00

Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases. Am J Physiol Regul Integr Comp Physiol (2013) 1.00

Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection. J Lipid Res (2013) 0.99

Hen Egg as an Antioxidant Food Commodity: A Review. Nutrients (2015) 0.98

Vitamin C in disease prevention and cure: an overview. Indian J Clin Biochem (2013) 0.98

Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest (1994) 0.98

Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am J Clin Nutr (2016) 0.98

Natural antioxidants and hypertension: promise and challenges. Cardiovasc Ther (2010) 0.98

Toll-like receptor 2 is essential for the sensing of oxidants during inflammation. Am J Respir Crit Care Med (2008) 0.97

Usefulness of Mendelian randomization in observational epidemiology. Int J Environ Res Public Health (2010) 0.97

Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role? Atherosclerosis (2008) 0.97

Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One (2013) 0.96

Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem J (1995) 0.95

Evidence based cardiology: emerging approaches in preventing cardiovascular disease. BMJ (1999) 0.94

On the mechanism of the anticlotting action of vitamin E quinone. Proc Natl Acad Sci U S A (1995) 0.94

Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels. Diabetes Care (2013) 0.93

Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest (1996) 0.93

Validity of advertising claims for multivitamin preparation Vitacor 20/90 on the internet. BMJ (1998) 0.92

Nutrition: risk factors for osteoarthritis. Ann Rheum Dis (1997) 0.90

Increased alpha-tocopherol content in soybean seed overexpressing the Perilla frutescens gamma-tocopherol methyltransferase gene. Plant Cell Rep (2006) 0.90

Natural bioactive compounds from winery by-products as health promoters: a review. Int J Mol Sci (2014) 0.90

Trace elements, heavy metals and vitamin levels in patients with coronary artery disease. Int J Med Sci (2011) 0.89

Haptoglobin genotype and its role in determining heme-iron mediated vascular disease. Pharmacol Res (2012) 0.89

Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione. J Card Fail (2007) 0.89

Why are low-density lipoproteins atherogenic? West J Med (1994) 0.88

Antioxidant nutrients, atherosclerosis, and coronary heart disease. Br Heart J (1995) 0.88

The effect of walnut intake on factors related to prostate and vascular health in older men. Nutr J (2008) 0.88

Antiatherogenic effects of the antioxidant BO-653 in three different animal models. Proc Natl Acad Sci U S A (1998) 0.88

Neither antioxidants nor genistein inhibit the progression of established atherosclerotic lesions in older apoE deficient mice. Atherosclerosis (2008) 0.88

Do free radicals play causal role in atherosclerosis? Low density lipoprotein oxidation and vitamin E revisited. J Clin Biochem Nutr (2010) 0.88

The shifting perception on antioxidants: the case of vitamin E and β-carotene. Redox Biol (2015) 0.88

Eotaxin increases monolayer permeability of human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol (2009) 0.87

The association of consumption of fruits/vegetables with decreased risk of glaucoma among older African-American women in the study of osteoporotic fractures. Am J Ophthalmol (2012) 0.86

Dietary approaches for management of cardio-vascular health- a review. J Food Sci Technol (2012) 0.86

Oxidized low-density lipoprotein induces the expression of P-selectin (GMP140/PADGEM/CD62) on human endothelial cells. Biochem J (1995) 0.86

Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants. Postgrad Med J (1994) 0.86

Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis. Vasc Health Risk Manag (2008) 0.86

Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial. BMC Nephrol (2008) 0.85

Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris. Heart (1998) 0.84

Functional foods and nutraceuticals in the primary prevention of cardiovascular diseases. J Nutr Metab (2012) 0.84

Dietary antioxidant capacity is associated with improved serum antioxidant status and decreased serum C-reactive protein and plasma homocysteine concentrations. Eur J Nutr (2013) 0.84

Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials. Nutrients (2010) 0.84

The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C. Metabolism (2009) 0.83

Regulatory metabolites of vitamin E and their putative relevance for atherogenesis. Redox Biol (2014) 0.83

Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes. World J Diabetes (2015) 0.83

Juice powder concentrate and systemic blood pressure, progression of coronary artery calcium and antioxidant status in hypertensive subjects: a pilot study. Evid Based Complement Alternat Med (2007) 0.82

Mechanisms of alterations in cardiac membrane Ca2+ transport due to excess catecholamines. Cardiovasc Drugs Ther (1996) 0.82

Articles by these authors

Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85

Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17

Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Body weight and mortality among women. N Engl J Med (1995) 11.04

Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98

Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84

Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57

Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11

Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90

Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90

Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28

Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05

Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66

Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60

Test of the National Death Index. Am J Epidemiol (1984) 8.46

Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43

Misinterpretation and misuse of the kappa statistic. Am J Epidemiol (1987) 8.29

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17

Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87

Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62

A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol (1990) 7.24

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11

Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09

Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med (2001) 7.07

Guidelines for healthy weight. N Engl J Med (1999) 7.03

Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02

Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02

Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50

Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol (1994) 6.47

The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37

Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med (2001) 6.23

Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med (1999) 6.21

Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21

Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med (1999) 6.17

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med (1991) 6.13

A prospective study of family history and the risk of colorectal cancer. N Engl J Med (1994) 6.12

A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med (1990) 6.06